|
Matignon Technologies I (Life Sciences : Medical Technologies) |
|
|
|
|
Matignon Technologies is a 50 M€ closed end venture capital fund for which subscriptions were closed in September 2000. The fund has at present 18 active investments in its portfolio, mainly French companies :
Life Sciences : Medical Technologies
 |
ALVEOLUS
American company specialised in the development of a next generation removeable stent and delivery device for non vascular applications.
www.alveolus.com
|
|
 |
A.R.T.
Company specialised in the development and commercialisation of stents (cardiovascular protheses).
http://www.art-sent.com/
|
|
 |
GLUCOLIGHT
Develops a non-invasive and continuous blood glucose monitor for home and hospital use.
http://www.glucolight.com/
|
|
 |
IPSOGEN
A technology company developing diagnostic products for cancer based on proprietary DNA biochips.
http://www.ipsogen.com/ |
|
|
|
|
Portfolio 
